334339
Characteristics of arthritis patients who seek medication information
Methods. Adult patients (n=328) with self-reported doctor-diagnosed osteoarthritis (OA) or rheumatoid arthritis (RA) were recruited from multiple sources and completed an online cross-sectional survey. Patients self-reported sociodemographic and clinical characteristics. Bivariate analyses were used to investigate the relationships between information source use, patient demographic and clinical characteristics of interest and information-seeking.
Results. The mean patient age was 56 years (±13; range 19–85). Most patients were female (79%) and white (80%) and the median arthritis duration was 11 years. There was a significant difference (all p<0.001) in arthritis patients seeking more information from professional (e.g., doctors, nurses) versus media sources (e.g., internet, brochures) (t(324)=9.93); professional versus informal interpersonal (e.g., friends, family) sources (t(321)= 21.57); and media versus informal interpersonal sources (t(321)= 14.51). Greater information-seeking was associated with greater arthritis severity, RA, black race, and college and lower levels of education. Patient age, arthritis duration, and age of diagnosis were not significantly associated with information-seeking.
Conclusion. Public health efforts related to medication education for arthritis patients should focus on professional and media source delivery and efforts should account for demographic and clinical differences in patient information-seeking.
Learning Areas:
Chronic disease management and preventionCommunication and informatics
Public health or related education
Learning Objectives:
Explain patient clinical and sociodemographic characteristics that are associated with arthritis medication information seeking.
Qualified on the content I am responsible for because: I am an assistant professor and have authored over 10 articles in the area of arthritis. I have been the PI of two arthritis studies.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.